Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats.

Herold MJ, van den Brandt J, Seibler J, Reichardt HM.

Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18507-12. doi: 10.1073/pnas.0806213105. Epub 2008 Nov 18.

2.

Inducible transgenic rat model for diabetes mellitus based on shRNA-mediated gene knockdown.

Kotnik K, Popova E, Todiras M, Mori MA, Alenina N, Seibler J, Bader M.

PLoS One. 2009;4(4):e5124. doi: 10.1371/journal.pone.0005124. Epub 2009 Apr 2.

3.

A novel lentivirus for quantitative assessment of gene knockdown in stem cell differentiation.

Alimperti S, Lei P, Tian J, Andreadis ST.

Gene Ther. 2012 Dec;19(12):1123-32. doi: 10.1038/gt.2011.208. Epub 2012 Jan 12. Review.

PMID:
22241174
4.
5.
6.

Doxycycline-dependent inducible and reversible RNA interference mediated by a single lentivirus vector.

Matsushita N, Matsushita S, Hirakawa S, Higashiyama S.

Biosci Biotechnol Biochem. 2013;77(4):776-81. Epub 2013 Apr 7.

7.

Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy.

Ren B, O'Brien BA, Swan MA, Koina ME, Nassif N, Wei MQ, Simpson AM.

Diabetologia. 2007 Sep;50(9):1910-20. Epub 2007 Jun 28.

8.
9.

A retro-lentiviral system for doxycycline-inducible gene expression and gene knockdown in cells with limited proliferative capacity.

Alexeyev MF, Fayzulin R, Shokolenko IN, Pastukh V.

Mol Biol Rep. 2010 Apr;37(4):1987-91. doi: 10.1007/s11033-009-9647-7. Epub 2009 Aug 5.

10.

Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.

Pluta K, Luce MJ, Bao L, Agha-Mohammadi S, Reiser J.

J Gene Med. 2005 Jun;7(6):803-17.

PMID:
15655804
11.

Reversible gene knockdown in mice using a tight, inducible shRNA expression system.

Seibler J, Kleinridders A, Küter-Luks B, Niehaves S, Brüning JC, Schwenk F.

Nucleic Acids Res. 2007;35(7):e54. Epub 2007 Mar 21.

12.

[Establishment of pancreatic ductal cell lines with stably silencing of MyD88 mediated by lentivirus].

Li Y, Zhou B, Chen KL, Liu Y, Lan Z, Li Y, Zhou ZG.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2011 May;42(3):293-7. Chinese.

PMID:
21826985
13.

Production of knockdown rats by lentiviral transduction of embryos with short hairpin RNA transgenes.

Dann CT, Garbers DL.

Methods Mol Biol. 2008;450:193-209. doi: 10.1007/978-1-60327-214-8_14.

PMID:
18370061
14.

Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells.

Cheng TL, Chang WT.

Methods Mol Biol. 2007;408:223-41. doi: 10.1007/978-1-59745-547-3_13.

PMID:
18314586
15.

Silencing the breast cancer resistance protein expression and function in caco-2 cells using lentiviral vector-based short hairpin RNA.

Zhang W, Li J, Allen SM, Weiskircher EA, Huang Y, George RA, Fong RG, Owen A, Hidalgo IJ.

Drug Metab Dispos. 2009 Apr;37(4):737-44. doi: 10.1124/dmd.108.023309. Epub 2009 Jan 8.

17.

Inducible and reversible lentiviral and Recombination Mediated Cassette Exchange (RMCE) systems for controlling gene expression.

Bersten DC, Sullivan AE, Li D, Bhakti V, Bent SJ, Whitelaw ML.

PLoS One. 2015 Mar 13;10(3):e0116373. doi: 10.1371/journal.pone.0116373. eCollection 2015.

18.

A versatile tool for conditional gene expression and knockdown.

Szulc J, Wiznerowicz M, Sauvain MO, Trono D, Aebischer P.

Nat Methods. 2006 Feb;3(2):109-16.

PMID:
16432520
19.

Gene therapy for diabetes mellitus in rats by intramuscular injection of lentivirus containing insulin gene.

Oh TK, Li MZ, Kim ST.

Diabetes Res Clin Pract. 2006 Mar;71(3):233-40. Epub 2005 Sep 19.

PMID:
16171885
20.

Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.

Johansen J, Rosenblad C, Andsberg K, Møller A, Lundberg C, Björlund A, Johansen TE.

Gene Ther. 2002 Oct;9(19):1291-301.

Items per page

Supplemental Content

Write to the Help Desk